Jae Wha Kim
21Patents
1h-index
68Co-inventors
56Inventor score
Filing activity: Mar 31, 2006 → Apr 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9895337B2 | Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis | Human Necessities | 2 | Active |
| US10058527B2 | Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis | Human Necessities | 1 | Active |
| US9075066B2 | CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer | Physics | 0 | Active |
| US11454309B2 | Composition for worm wheel having excellent durability with wear resistance and worm wheel prepared using the same | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US10857119B2 | Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis | Human Necessities | 0 | Active |
| US9763908B2 | Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis | Human Necessities | 0 | Active |
| US9174925B2 | Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same | Chemistry; Metallurgy | 0 | Active |
| US10596141B2 | Methods for treating thrombocytopenia | Human Necessities | 0 | Active |
| US9481630B2 | Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same | Chemistry; Metallurgy | 0 | Active |
| US9375456B2 | Antiviral composition containing an Aleurites fordii or Daphne kiusiana extract or a fraction thereof as an active ingredient | Human Necessities | 0 | Active |
| US12187672B2 | 1,2-diacylglycerol compound, preparation method therefor, and immunomodulator containing same as active ingredient | Chemistry; Metallurgy | 0 | Active |
| US8283129B2 | Characterization of ESM-1 as a tumor associated marker of colorectal cancer | Chemistry; Metallurgy | 0 | Active |
| US11357749B2 | Methods for treating neutropenia | Human Necessities | 0 | Active |
| US9428520B2 | Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis | Human Necessities | 0 | Active |
| US11491132B2 | Methods for treating thrombocytopenia | Human Necessities | 0 | Active |
| US12297163B2 | Glycerol derivative, preparation method therefor, and immunomodulator comprising same as effective ingredient | Chemistry; Metallurgy | 0 | Active |
| US10588886B2 | Methods for treating neutropenia | Human Necessities | 0 | Active |
| US10555923B2 | Method for treating paroxysmal nocturnal hemoglobinuria | Human Necessities | 0 | Active |
| US7718780B2 | Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip | Physics | 0 | Active |
| US9061022B2 | Pharmaceutical composition for treating wounds or revitalizing skin comprising Euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient | Human Necessities | 0 | Active |
| US10653657B2 | Method for treating hemolytic uremic syndrome | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.